Registered entities
Addrenex Pharmaceuticals
Reg. No. 20-5131243United States
Innovation
1 patent family — focus: Human necessities; filing pace dormant. Cited 151 times.
Investor mix
2 investors on record; lead investors include Sciele Pharma.
| Investor type | Count | Share |
|---|---|---|
| Accelerator & incubator | 1 | 50% |
| Other / undisclosed | 1 | 50% |